1. Schliephake H, Knebel JW, Aufderheide M, et al. Use of cultivated osteoprogenitor cells to increase bone formation in segmental mandibular defects: an experimental pilot study in sheep. Int J Oral Maxillofac Surg 2001; 30: 531–537.
2. Schliephake H, Weich HA, Dullin C, et al. Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid – an experimental study in rats. Biomaterials 2008; 29: 103–110.
3. Yuan J, Cui L, Zhang WJ, et al. Repair of canine mandibular bone defects with bone marrow stromal cells and porous beta-tricalcium phosphate. Biomaterials 2007; 28: 1005–1013.
4. Lynch S, Marx RE, Nevins M, et al. Tissue engineering application in oral & maxillofacial surgery and periodontics. 2nd ed. Quintessence Publishing, Hanover, 2008, pp. 9–15.
5. Liu F, Porter RM, Wells J, et al. Evaluation of BMP-2 gene-activated muscle grafts for cranial defect repair. J Orthop Res 2012; 30: 1095–1102.
6. Shore EM and Laplan FS. Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP). Bone 2008; 43: 427–433.
7. Stoltny T, Koczy B, Wawrzynek W, et al. Heterotopic ossification in patients after total hip replacement. Ortop Traumatol Rehabil 2007; 9: 264–272.
8. Covey DC. Combat orthopaedics: a view from the trenches. J Am Acad Orthop Surg 2006; 14: S10–S17.
9. Hou Q, De Bank P and Shakesheff K. Injectable scaffolds for tissue regeneration. J Mater Chem 2004; 14: 1915–1923.
10. Huang Z, Tian J, Yu B, et al. A bone-like nano-hydroxyapatite/collagen loaded injectable scaffold. Biomed Mater 2009; 4: 550–555.
11. Rauschmann MA, Wichelhaus TA, Stirnal V, et al. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials 2005; 26: 2677–2684.
12. Hu G, Xiao L, Fu H, et al. Study on injectable and degradable cement of calcium sulphate and calcium phosphate for bone repair. J Mater Sci Mater Med 2010; 21: 627–634.
13. Nilsson M, Wielanek L, Wang J-S, et al. Factors influencing the compressive strength of an injectable calcium sulfate-hydroxyapatite cement. J Mater Sci Mater Med 2003; 14: 399–404.
14. Nilsson M. Injectable calcium sulphate and calcium phosphate bone substitutes. PhD Thesis, Faculty of Medicine, Lund University, Lund, 2003, Paper II, pp. 1–8.
15. Masala S, Nano G, Marcia S, et al. Osteoporotic vertebral compression fractures augmentation by injectable partly resorbable ceramic bone substitute (Cerament™⎪SPINE SUPPORT): a prospective nonrandomized study. Neuroradiology 2012; 54: 589–596.
16. Karr JC. Management in the wound-care center outpatient setting of a diabetic patient with forefoot osteomyelitis using Cerament Bone Void Filler impregnated with vancomycin: off-label use. J Am Podiatr Med Assoc 2011; 2011(101): 259–264.
17. Karr JC, Lauretta J and Keriazes G. In vitro antimicrobial activity of calcium sulfate and hydroxyapatite (Cerament Bone Void Filler) discs using heat-sensitive and non-heat-sensitive antibiotics against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. J Am Podiatr Med Assoc 2011; 101: 146–152.
18. Rauschmann M, Vogl T, Verheyden A, et al. Bioceramic vertebral augmentation with a calcium sulphate/hydroxyapatite composite (Cerament™ Spine Support) in vertebral compression fractures due to osteoporosis. Eur Spine J 2010; 19: 887–892.
19. Marcia S, Boi C, Dragani M, et al. Effectiveness of a bone substitute (ΧΕΡΑΜΕΝΤ™) as an alternative to PMMA in percutaneous vertebroplasty: 1-year follow-up on clinical outcome. Eur Spine J 2012; 21(Suppl. 1): S112–S118.
20. Hatten H and Voor M. Bone healing using a bi-phasic ceramic bone substitute demonstrated in human vertebroplasty and with histology in a rabbit cancellous bone defect model. Interv Neuroradiol 2012; 18: 105–113.
21. Busuttil Naudi K, Ayoub A, McMahon J, et al. Mandibular reconstruction in the rabbit using beta-tricalcium phosphate (beta-TCP) scaffolding and recombinant bone morphogenetic protein 7 (rhBMP-7) – histological, radiographic and mechanical evaluations. J Craniomaxillofac Surg 2012; 40: e461–e469.
22. Allen M, Myer B and Rushton N. In vitro and in vivo investigations into the biocompatibility of diamond-like carbon (DLC) coatings for orthopedic applications. J Biomed Mater Res 2001; 58: 319–328.
23. O’Hare P, Meenan BJ, Burke GA, et al. Biological responses to hydroxyapatite surfaces deposited via a co-incident microblasting technique. Biomaterials 2010; 31: 515–522.
24. Ormsby R, McNally T, O’Hare P, et al. Fatigue and biocompatibility properties of a poly(methyl methacrylate) bone cement with multi-walled carbon nanotubes. Acta Biomater 2012; 8: 1201–1212.
25. Moreau JL and Xu HH. Mesenchymal stem cell proliferation and differentiation on an injectable calcium phosphate-chitosan composite scaffold. Biomaterials 2009; 30: 2675–2682.
26. Liao S, Chen C and Ramakrishna S. Stem cells and biomimetic materials strategies for tissue engineering. Mat Sci Eng C 2008; 28: 1189–1202.
27. Dalby MJ, Yarwood SJ, Riehle MO, et al. Increasing fibroblast response to materials using nanotopography: morphological and genetic measurements of cell response to 13-nm-high polymer demixed islands. Exp Cell Res 2002; 276: 1–9.
28. Lai M, Cai KY, Hu Y, et al. Regulation of the behaviors of mesenchymal stem cells by surface nanostructured titanium. Colloids Surf B Biointerfaces 2012; 97: 211–220.
29. Yim EKF, Pang SW and Leong KW. Synthetic nanostructures inducing differentiation of human mesenchymal stem cells into neuronal lineage. Exp Cell Res 2007; 313: 1820–1829.
30. Kokubo S, Fujimoto R, Yokota S, et al. Bone regeneration by recombinant human bone morphogenetic protein-2 and a novel biodegradable carrier in a rabbit ulnar defect model. Biomaterials 2003; 24: 1643–1651.
31. Lo KW, Ulery BD, Ashe KM, et al. Studies of bone morphogenetic protein-based surgical repair. Adv Drug Deliv Rev 2012; 64(12): 1277–1291.
32. McBeath R, Pirone DM, Nelson CM, et al. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 2004; 6: 483–495.
33. Coetzee AS. Regeneration of bone in the presence of calcium-sulfate. Arch Otolaryngol 1980; 106: 405–409.
34. Strocchi R, Orsini G, Iezzi G, et al. Bone regeneration with calcium sulfate: evidence for increased angiogenesis in rabbits. J Oral Implantol 2002; 28: 273–278.
35. Walsh WR, Morberg P, Yu Y, et al. Response of a calcium sulfate bone graft substitute in a confined cancellous defect. Clin Orthop Relat Res 2003; 406: 228–226.
36. Thomas MV and Puleo DA. Calcium sulfate: properties and clinical applications. J Biomed Mater Res B Appl Biomater 2009; 88: 597–610.
37. Park EK, Lee YE, Choi JY, et al. Cellular biocompatibility and stimulatory effects of calcium metaphosphate on osteoblastic differentiation of human bone marrow-derived stromal cells. Biomaterials 2004; 25: 3403–3411.
38. Lazary A, Balla B, Kosa JP, et al. Effect of gypsum on proliferation and differentiation of MC3T3-E1 mouse osteoblastic cells. Biomaterials 2007; 28: 393–399.
39. Jager M and Wilke A. Comprehensive biocompatibility testing of a new PMMA-HA bone cement versus conventional PMMA cement in vitro. J Biomater Sci Polym Ed 2003; 14: 1283–1298.
40. Simon CGJ, Guthrie WF and Wang FW. Cell seeding into calcium phosphate cement. J Biomed Mater Res A 2004; 68: 628–639.
41. Chow L, Takagi S, Costantino P, et al. Self-setting calcium phosphate cements. Mater Res Soc Symp P 1991; 179: 23–24.
42. Huan Z and Chang J. Self-setting properties and in vitro bioactivity of calcium sulfate hemihydrate-tricalcium silicate composite bone cements. Acta Biomater 2007; 3: 952–960.
43. Khadka A, Li J, Li Y, et al. Evaluation of hybrid porous biomimetic nano hydroxyapatite/polyamide 6 and bone marrow-derived stem cell construct in repair of calvarial critical size defect. J Craniofac Surg 2011; 22: 1852–1858.